Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 2/2018

01-02-2018 | Perspective

Advancing the Science and Practice of Medication Adherence

Authors: Michael J. Stirratt, PhD, Jeffrey R. Curtis, MD, MS, MPH, Maria I. Danila, MD, MSc, MSPH, Richard Hansen, PhD, RPh, FAPhA, Michael J. Miller, RPh, DrPH, FAPhA, C. Ann Gakumo, PhD, RN

Published in: Journal of General Internal Medicine | Issue 2/2018

Login to get access

Abstract

Medication adherence remains a significant unmet challenge for optimizing patient outcomes. Recent advances in the conceptualization, measurement, and support of medication adherence offer fresh opportunities to make a meaningful impact on adherence-related behavior and outcomes. These advances emphasize the multifaceted and dynamic nature of medication adherence, provide novel methods for monitoring medication adherence in clinical care, and articulate a set of multilevel strategies to more effectively improve and sustain medication adherence. Here, we offer recommendations for how clinicians can better engage with, and benefit from, these innovations to improve patient medication adherence and associated treatment outcomes.
Literature
1.
Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28(4):437-43.CrossRefPubMedPubMedCentral
2.
Vink NM, Klungel OH, Stolk RP, Denig P. Comparison of various measures for assessing medication refill adherence using prescription data. Pharmacoepidemiol Drug Saf. 2009;18(2):159-65.CrossRefPubMed
3.
Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009;15(9):728-40.PubMed
4.
Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014(11):CD000011.
5.
6.
Steiner JF. Self-reported adherence measures: what do they assess and how should we use them? Med Care. 2012;50(12):1011-2.CrossRefPubMed
7.
Voils CI, Hoyle RH, Thorpe CT, Maciejewski ML, Yancy WS, Jr. Improving the measurement of self-reported medication nonadherence. J Clin Epidemiol. 2011;64(3):250-4.CrossRefPubMed
8.
Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691-705.
9.
Fischer MA, Stedman MR, Lii J, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25(4):284-90.
10.
Hutchins DS, Zeber JE, Roberts CS, et al. Initial medication adherence-review and recommendations for good practices in outcomes research: an ISPOR medication adherence and persistence special interest group report. Value Health. 2015;18(5):690-9.
11.
DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200-9.CrossRefPubMed
12.
Curtis JR, Xi J, Westfall AO, et al. Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis. Med Care. 2009;47(3):334-41.
13.
Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40(7–8):1280-88.CrossRefPubMed
14.
Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105-16.CrossRefPubMed
15.
Blaschke TF, Osterberg L, Vrijens B, Urquhart J. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol. 2012;52:275-301.CrossRefPubMed
16.
Mathews R, Wang TY, Honeycutt E, et al. Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study. Am Heart J. 2015;170(1):62-9.
17.
18.
Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288(4):455-61.CrossRefPubMed
19.
Wilson IB, Bangsberg DR, Shen J, et al. Heterogeneity among studies in rates of decline of antiretroviral therapy adherence over time: results from the multisite adherence collaboration on HIV 14 study. J Acquir Immune Defic Syndr. 2013;64(5):448-54.
20.
Hommel KA, McGrady ME, Peugh J, et al. Longitudinal patterns of medication nonadherence and associated health care costs. Inflamm Bowel Dis. 2017;23(9):1577-83.
21.
Knafl GJ, Bova CA, Fennie KP, O'Malley JP, Dieckhaus KD, Williams AB. An analysis of electronically monitored adherence to antiretroviral medications. AIDS Behav. 2010;14(4):755-68.CrossRefPubMed
22.
Franklin JM, Shrank WH, Pakes J, et al. Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence. Med Care. 2013;51(9):789-96.
23.
Cambiano V, Lampe FC, Rodger AJ, et al. Long-term trends in adherence to antiretroviral therapy from start of HAART. AIDS (London, England). 2010;24(8):1153-62.
24.
French T, Tesoriero J, Agins B. Changes in stress, substance use and medication beliefs are associated with changes in adherence to HIV antiretroviral therapy. AIDS Behav. 2011;15(7):1416-28.CrossRefPubMed
25.
26.
Hansen RA, Dusetzina SB, Dominik RC, Gaynes BN. Prescription refill records as a screening tool to identify antidepressant non-adherence. Pharmacoepidemiol Drug Saf. 2010;19(1):33-7.CrossRefPubMedPubMedCentral
27.
28.
29.
Gonzalez JS, Schneider HE. Methodological issues in the assessment of diabetes treatment adherence. Curr Diab Rep. 2011;11(6):472-9.CrossRefPubMed
30.
Whalley Buono E, Vrijens B, Bosworth HB, Liu LZ, Zullig LL, Granger BB. Coming full circle in the measurement of medication adherence: opportunities and implications for health care. Patient Prefer Adherence. 2017;11:1009-17.CrossRefPubMedPubMedCentral
31.
Chesney MA. The elusive gold standard. Future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr. 2006;43 Suppl 1:S149-55.CrossRefPubMed
32.
Zullig LL, Mendys P, Bosworth HB. Medication adherence: A practical measurement selection guide using case studies. Patient Educ Couns. 2017;100(7):1410-4.CrossRefPubMed
33.
Campbell JI, Haberer JE. Cell Phone-Based and Adherence Device Technologies for HIV Care and Treatment in Resource-Limited Settings: Recent Advances. Curr HIV/AIDS Rep. 2015;12(4):523-31.CrossRefPubMed
34.
Hafezi H, Robertson TL, Moon GD, Au-Yeung KY, Zdeblick MJ, Savage GM. An ingestible sensor for measuring medication adherence. IEEE Trans Biomed Eng. 2015;62(1):99-109CrossRefPubMed
35.
Kane JM, Perlis RH, DiCarlo LA, Au-Yeung K, Duong J, Petrides G. First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder. J Clin Psychiatry. 2013;74(6):e533-40.CrossRefPubMed
36.
Peters-Strickland T, Pestreich L, Hatch A, et al. Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole. Neuropsychiatr Dis Treat. 2016;12:2587-94.
37.
Thompson D, Mackay T, Matthews M, Edwards J, Peters N, Connolly SB. Direct adherence measurement using an ingestible sensor compared with self-reporting in high-risk cardiovascular disease patients who knew they were being measured: a prospective intervention. JMIR Mhealth Uhealth. 2017;5(6):e76.CrossRefPubMedPubMedCentral
38.
Gupta P, Patel P, Strauch B, et al. Risk Factors for Nonadherence to Antihypertensive Treatment. Hypertension. 2017;69(6):1113-20.
39.
McNaughton CD, Brown NJ, Rothman RL, et al. Systolic Blood Pressure and Biochemical Assessment of Adherence: A cross-sectional analysis in the emergency department. Hypertension. 2017;70(2):307-14.
40.
Zheng JH, Rower C, McAllister K, Castillo-Mancilla J, et al. Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots. J Pharm Biomed Anal. 2016;122:16-20.
41.
Stirratt MJ, Dunbar-Jacob J, Crane HM, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5(4):470-82.
42.
Feldman BJ, Fredericksen RJ, Crane PK, et al. Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav. 2013;17(1):307-18.
43.
44.
Callon W, Saha S, Korthuis PT, et al. Which clinician questions elicit accurate disclosure of antiretroviral non-adherence when talking to patients? AIDS Behav. 2016;20(5):1108-15.
45.
46.
47.
Lester RT, Ritvo P, Mills EJ, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376(9755):1838-45.
48.
Choudhry NK, Bykov K, Shrank WH, Toscano M, Rawlins WS, Reisman L, et al. Eliminating medication copayments reduces disparities in cardiovascular care. Health Aff (Millwood). 2014;33(5):863-70.CrossRefPubMed
49.
Coca A, Agabiti-Rosei E, Cifkova R, Manolis AJ, Redon J, Mancia G. The polypill in cardiovascular prevention: evidence, limitations and perspective - position paper of the European Society of Hypertension. J Hypertens. 2017;35(8):1546-53.CrossRefPubMed
50.
Siegel SJ. Extended release drug delivery strategies in psychiatry: theory to practice. Psychiatry. 2005;2(6):22-31.
51.
Krumme AA, Isaman DL, Stolpe SF, Dougherty S, Choudhry NK. Prevalence, effectiveness, and characteristics of pharmacy-based medication synchronization programs. Am J Manag Care. 2016;22(3):179-86.PubMed
52.
Girdish C, Shrank W, Freytag S, et al. The impact of a retail prescription synchronization program on medication adherence. J Am Pharm Assoc (2003). 2017.
53.
Choudhry NK, Krumme AA, Ercole PM, et al. Effect of reminder devices on medication adherence: the REMIND randomized clinical trial. JAMA Intern Med. 2017;177(5):624-31.
54.
Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Annals of internal medicine. 2012;157(11):785-95.
55.
Kronish IM, Moise N. In search of a "magic pill" for medication nonadherence. JAMA Intern Med. 2017;177(5):631-2.
56.
DeKoekkoek T, Given B, Given CW, Ridenour K, Schueller M, Spoelstra SL. mHealth SMS text messaging interventions and to promote medication adherence: An integrative review. Journal of Clinical Nursing. 2015;24(19–20):2722-35.CrossRefPubMed
57.
Davidson TM, McGillicuddy J, Mueller M, et al. Evaluation of an mHealth medication regimen self-management program for African American and Hispanic uncontrolled hypertensives. J Pers Med. 2015;5(4):389-405.
58.
Kronish IM, Moise N, McGinn T, et al. An electronic adherence measurement intervention to reduce clinical inertia in the treatment of uncontrolled hypertension: the MATCH cluster randomized clinical trial. J Gen Intern Med. 2016;31(11):1294-300.
59.
Wilson IB, Laws MB, Safren SA, et al. Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIV. J Acquir Immune Defic Syndr. 2010a;53(3):338-47.
60.
Jones DL, Sued O, Cecchini D, et al. Improving adherence to care among "hard to reach" HIV-infected patients in Argentina. AIDS Behav. 2016;20(5):987-97.
61.
Wilson SR, Strub P, Buist AS, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med. 2010b;181(6):566-77.
62.
Adams AS, Uratsu C, Dyer W, et al. Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users. JAMA Intern Med. 2013;173(1):54-61.
63.
Horberg MA, Hurley LB, Towner WJ, et al. Determination of optimized multidisciplinary care team for maximal antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2012;60(2):183-90.
Metadata
Title
Advancing the Science and Practice of Medication Adherence
Authors
Michael J. Stirratt, PhD
Jeffrey R. Curtis, MD, MS, MPH
Maria I. Danila, MD, MSc, MSPH
Richard Hansen, PhD, RPh, FAPhA
Michael J. Miller, RPh, DrPH, FAPhA
C. Ann Gakumo, PhD, RN
Publication date
01-02-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 2/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-017-4198-4

Other articles of this Issue 2/2018

Journal of General Internal Medicine 2/2018 Go to the issue

Concise Research Reports

Are Demographic Characteristics Associated with Advance Directive Completion? A Secondary Analysis of Two Randomized Trials

Perspective

Cultural Issues in Medication Adherence: Disparities and Directions

OriginalPaper

Periorbital edema from apixaban treatment

Clinical Practice: Clinical Images

Acute Shoulder Pain Followed by Shoulder Weakness and Atrophy: A Characteristic Presentation of Parsonage-Turner Syndrome

Concise Research Reports

What Does ‘Unpaid Consultant’ Signify? A Survey of Euphemistic Language in Conflict of Interest Declarations

Perspective

Advantages to Using Social-Behavioral Models of Medication Adherence in Research and Practice

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits